2327 — Meilleure Health International Industry Income Statement
0.000.00%
Last trade - 00:00
- HK$736.66m
- HK$927.58m
- HK$129.30m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 235 | 265 | 253 | 120 | 129 |
Cost of Revenue | |||||
Gross Profit | 71.8 | 111 | 101 | 66.8 | 78.1 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 202 | 144 | 148 | 68.3 | 60.6 |
Operating Profit | 32.8 | 121 | 105 | 51.6 | 68.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.34 | 104 | 85.7 | 25.4 | 53 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23 | 85.1 | 60.5 | 17.8 | 38.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -20.2 | 83.4 | 60.3 | 17.8 | 40.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -20.2 | 83.4 | 60.3 | 17.8 | 40.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | 0.011 | 0.012 | 0.003 | 0.011 |
Dividends per Share |